{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:48:38Z","timestamp":1778507318073,"version":"3.51.4"},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej16-0194","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T18:09:31Z","timestamp":1471543771000},"page":"983-990","source":"Crossref","is-referenced-by-count":17,"title":["Lower body weight and BMI at birth were associated with early adiposity rebound in 21-hydroxylase deficiency patients"],"prefix":"10.1507","volume":"63","author":[{"given":"Shigeru","family":"Takishima","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"},{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumi","family":"Tsuji-Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"},{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Miyai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"},{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takasawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kashimada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, <i>et al<\/i>. (2010) Clinical review: Adult height in patients with congenital adrenal hyper-plasia: a systematic review and metaanalysis. <i>J Clin Endocrinol Metab <\/i>95: 4161-4172.","DOI":"10.1210\/jc.2009-2616"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Newfield RS, New MI (1997) 21-hydroxylase deficiency. <i>Ann N Y Acad Sci<\/i> 816: 219-229.","DOI":"10.1111\/j.1749-6632.1997.tb52145.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Speiser PW, White PC (2003) Congenital adrenal hyperplasia. <i>N Engl J Med <\/i>349: 776-788.","DOI":"10.1056\/NEJMra021561"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jaaskelainen J, Voutilainen R (1996) Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. <i>Clin Endocrinol (Oxf)<\/i> 45: 707-713.","DOI":"10.1046\/j.1365-2265.1996.8620871.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cornean RE, Hindmarsh PC, Brook CG (1998) Obesity in 21-hydroxylase deficient patients. <i>Arch Dis Child <\/i>78: 261-263.","DOI":"10.1136\/adc.78.3.261"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Charmandari E, Chrousos GP (2006) Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardio-vascular disease and secondary polycystic ovary syndrome? <i>Ann N Y Acad Sci<\/i> 1083: 37-53.","DOI":"10.1196\/annals.1367.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, <i>et al<\/i>. (2012) Clinical characteristics of a cohort of 244 patients with congenital adrenal hy-perplasia. <i>J Clin Endocrinol Metab <\/i>97: 4429-4438.","DOI":"10.1210\/jc.2012-2102"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Han TS, Stimson RH, Rees DA, Krone N, Willis DS, <i>et al<\/i>. (2013) Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia. <i>Clin Endocrinol (Oxf)<\/i> 78: 197-203.","DOI":"10.1111\/cen.12045"},{"key":"9","unstructured":"9. Kemink SA, Frijns JT, Hermus AR, Pieters GF, Smals AG, <i>et al<\/i>. (1999) Body composition determined by six different methods in women bilaterally adrenalectomized for treatment of Cushing&rsquo;s disease. <i>J Clin Endocrinol Metab <\/i>84: 3991-3999."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hiort O, Birnbaum W, Marshall L, Wunsch L, Werner R, <i>et al<\/i>. (2014) Management of disorders of sex development. <i>Nat Rev Endocrinol<\/i> 10: 520-529.","DOI":"10.1038\/nrendo.2014.108"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matsubara Y, Ono M, Miyai K, Takizawa F, Takasawa K, <i>et al<\/i>. (2013) Longitudinal analysis of growth and body composition of Japanese 21-OHD patients in childhood. <i>Endocr J<\/i> 60: 149-154.","DOI":"10.1507\/endocrj.EJ12-0123"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mooij CF, Kroese JM, Claahsen-van der Grinten HL, Tack CJ, Hermus AR (2010) Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? <i>Clin Endocrinol (Oxf)<\/i> 73: 137-146.","DOI":"10.1111\/j.1365-2265.2009.03690.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. <i>Lancet<\/i> 365: 2125-2136.","DOI":"10.1016\/S0140-6736(05)66736-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Williams SM, Goulding A (2009) Patterns of growth associated with the timing of adiposity rebound. <i>Obesity (Silver Spring)<\/i> 17: 335-341.","DOI":"10.1038\/oby.2008.547"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Taylor RW, Grant AM, Goulding A, Williams SM (2005) Early adiposity rebound: review of papers linking this to subsequent obesity in children and adults. <i>Curr Opin Clin Nutr Metab Care<\/i> 8: 607-612.","DOI":"10.1097\/01.mco.0000168391.60884.93"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chivers P, Hands B, Parker H, Bulsara M, Beilin LJ, <i>et al<\/i>. (2010) Body mass index, adiposity rebound and early feeding in a longitudinal cohort (Raine Study). <i>Int J Obes (Lond)<\/i> 34: 1169-1176.","DOI":"10.1038\/ijo.2010.61"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Naruse H, Suzuki E, Irie M Tsuji A, Takasugi N, <i>et al<\/i>. (1985) Ne-onatal screening for congenital adrenal hyperplasia in Japan. <i>Ann N Y Acad Sci<\/i> 458: 103-110.","DOI":"10.1111\/j.1749-6632.1985.tb14596.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shimozawa K, Saisho S, Saito N, Yata J, Igarashi Y, <i>et al<\/i>. (1984) A neonatal mass-screening for congenital adrenal hyperplasia in Japan. <i>Acta Endo-crinol (Copenh)<\/i> 107: 513-518.","DOI":"10.1530\/acta.0.1070513"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Whitaker RC, Pepe MS, Wright JA, Seidel KD, Dietz WH (1998) Early ad-iposity rebound and the risk of adult obesity. <i>Pediatrics<\/i> 101: E5.","DOI":"10.1542\/peds.101.3.e5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kusuda S, Tachibana K, Saisho S, Yokota I, Igarashi Y, <i>et al<\/i>. (1999) Guideline for the Treatment of Patients with 21-OHase Deficiency Detected by Neonatal Screening (Revised in 1999). <i>Clin Pediatr Endocrinol<\/i> 8: 61-65.","DOI":"10.1297\/cpe.8.61"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Koyama S, Ichikawa G, Kojima M, Shimura N, Sairenchi T, <i>et al<\/i>. (2014) Adiposity rebound and the development of metabolic syndrome. <i>Pediatrics<\/i> 133: e114-119.","DOI":"10.1542\/peds.2013-0966"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Falhammar H, Thoren M (2012) Clinical outcomes in the management of congenital adrenal hyperplasia. <i>Endocrine<\/i> 41: 355-373.","DOI":"10.1007\/s12020-011-9591-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Knowles RL, Khalid JM, Oerton JM, Hindmarsh PC, Kelnar CJ, <i>et al<\/i>. (2014) Late clinical presentation of congenital adrenal hyperplasia in older children: findings from national paediatric surveillance. <i>Arch Dis Child<\/i> 99: 30-34.","DOI":"10.1136\/archdischild-2012-303070"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. <i>Am J Epidemiol<\/i> 165: 849-857.","DOI":"10.1093\/aje\/kwk071"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tsuji A, Konishi K, Hasegawa S, Anazawa A, Onishi T, <i>et al<\/i>. (2015) Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study. <i>BMC Pediatr<\/i> 15: 209.","DOI":"10.1186\/s12887-015-0529-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Williams S, Dickson N (2002) Early growth, menarche, and adiposity re-bound. <i>Lancet<\/i> 359: 580-581.","DOI":"10.1016\/S0140-6736(02)07715-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE, Herkimer C (2010) Developmental programming: impact of prenatal testosterone excess and post-natal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. <i>Endocrinology<\/i> 151: 595-605.","DOI":"10.1210\/en.2009-1015"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Roland AV, Nunemaker CS, Keller SR, Moenter SM (2010) Prenatal an-drogen exposure programs metabolic dysfunction in female mice. <i>J Eendocrinol <\/i>207: 213-223.","DOI":"10.1677\/JOE-10-0217"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Abbott DH, Tarantal AF, Dumesic DA (2009) Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. <i>Am J Primatol<\/i> 71: 776-784.","DOI":"10.1002\/ajp.20679"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yan X, Dai X, Wang J, Zhao N, Cui Y, <i>et al<\/i>. (2013) Prenatal androgen excess programs metabolic derangements in pubertal female rats. <i>J Eendocrinol <\/i>217: 119-129.","DOI":"10.1530\/JOE-12-0577"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Bruns CM, Baum ST, Colman RJ, Eisner JR, Kemnitz JW, <i>et al<\/i>. (2004) Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. <i>J Clin Endocrinol Metab <\/i>89: 6218-6223.","DOI":"10.1210\/jc.2004-0918"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kroke A, Hahn S, Buyken AE, Liese AD (2006) A comparative evaluation of two different approaches to estimating age at adiposity rebound. <i>Int J Obes (Lond)<\/i> 30: 261-266.","DOI":"10.1038\/sj.ijo.0803143"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Dorosty AR, Emmett PM, Cowin S, Reilly JJ (2000) Factors associated with early adiposity rebound. ALSPAC Study Team. <i>Pediatrics<\/i> 105: 1115-1118.","DOI":"10.1542\/peds.105.5.1115"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/11\/63_EJ16-0194\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T13:56:01Z","timestamp":1568296561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/11\/63_EJ16-0194\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0194","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}